Amyloid and its association with default network integrity in Alzheimer's disease

Human Brain Mapping

Volumn 35, Issue 3, 2014, Pages 779-791

  Adriaanse, Sofie M ^a   Sanz Arigita, Ernesto J ^a,b   Binnewijzend, Maja A A ^a   Ossenkoppele, Rik ^a   Tolboom, Nelleke ^a   van Assema, Daniëlle M E ^a   Wink, Alle Meije ^a   Boellaard, Ronald ^a   Yaqub, Maqsood ^a   Windhorst, Albert D ^a   van der Flier, Wiesje M ^a   Scheltens, Philip ^a   Lammertsma, Adriaan A ^a   Rombouts, Serge A R B ^c,d   Barkhof, Frederik ^a   van Berckel, Bart N M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Foundation CITA Alzheimer   (Spain)

^c LEIDEN UNIVERSITY   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer disease; Amyloid; Default mode network; Magnetic resonance imaging; Mild cognitive impairment; Positron emission tomography; Resting state fMRI

Indexed keywords

2-(4'-(METHYLAMINO)PHENYL)-6-HYDROXYBENZOTHIAZOLE; AMYLOID BETA PROTEIN; ANILINE DERIVATIVE; THIAZOLE DERIVATIVE;

AGED; AGING; ALZHEIMER DISEASE; BRAIN; COMPARATIVE STUDY; DEVICES; DIAGNOSTIC USE; FEMALE; FUNCTIONAL NEUROIMAGING; HUMAN; MALE; METABOLISM; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NERVE CELL NETWORK; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES;

AGED; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANILINE COMPOUNDS; BRAIN; FEMALE; FUNCTIONAL NEUROIMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NERVE NET; POSITRON-EMISSION TOMOGRAPHY; THIAZOLES;

EID: 84893756556     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.22213     Document Type: Article

References (45)

1. Beckmann CF, Mackay CE, Filippini N, Smith SM (2009): Group comparison of resting-state fMRI data using multi-subject ICA and dual regression. Neuroimage 47 (Suppl 1):S148.
2. Binnewijzend MAA, Schoonheim MM, Sanz-Arigita E, Wink AM, van der Flier WM, Tolboom N, Adriaanse SM, Damoiseaux JS, Scheltens P, van Berckel BNM, Barkhof F (2012): Resting-state fMRI changes in Alzheimer's disease and mild cognitive impairment. Neurobiol Aging 33:2018-2028.
3. Biswal B, Yetkin FZ, Haughton VM, Hyde JS (1995): Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med 34:537-541.
4. Biswal BB, Mennes M, Zuo XN, Gohel S, Kelly C, Smith SM, Beckmann CF, Adelstein JS, Buckner RL, Colcombe S, Dogonowski AM, Ernst M, Fair D, Hampson M, Hoptman MJ, Hyde JS, Kiviniemi VJ, Kötter R, Li SJ, Lin CP, Lowe MJ, Mackay C, Madden DJ, Madsen KH, Margulies DS, Mayberg HS, McMahon K, Monk CS, Mostofsky SH, Nagel BJ, Pekar JJ, Peltier SJ, Petersen SE, Riedl V, Rombouts SA, Rypma B, Schlaggar BL, Schmidt S, Seidler RD, Siegle GJ, Sorg C, Teng GJ, Veijola J, Villringer A, Walter M, Wang L, Weng XC, Whitfield-Gabrieli S, Williamson P, Windischberger C, Zang YF, Zhang HY, Castellanos FX, Milham MP (2010): Toward discovery science of human brain function. Proc Natl Acad Sci USA 107:4734-4739.
5. Boellaard R, van Lingen A, Lammertsma AA (2001): Experimental and clinical evaluation of iterative reconstruction (OSEM) in dynamic PET: Quantitative characteristics and effects on kinetic modelling. J Nucl Med 42:808-817.
6. Brix G, Zaers J, Adam LE, Bellemann ME, Ostertag H, Trojan H, Haberkorn U, Doll J, Oberdorfer F, Lorenz WJ (1997): Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. J Nucl Med 38:1614-1623.
7. Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, Sheline YI, Klunk WE, Mathis CA, Morris JC, Mintun MA (2005): Molecular, structural, and functional characterization of Alzheimer's disease: Evidence for a relationship between default activity, amyloid and memory. Neurobiol Dis 25:7709-7717.
8. Buckner RL, Sepulcre J, Talukdar T, Krienen FM, Liu H, Hedden T, Andrews-Hanna JR, Sperling RA, Johnson KA (2009): Cortical hubs revealed by intrinsic functional connectivity: Mapping, assessment of stability and relation to Alzheimer's disease. Neurobiol Dis 29:1860-1873.
9. Calhoun VD, Adali T, Pearlson GD, Pekar JJ (2001): A method for making group inferences from functional MRI using independent component analysis. Hum Brain Mapp 14:140-151.
10. Cirrito JR, Kang JE, Lee J, Stewart FR, Verges DK, Silverio LM, Bu G, Mennerick S, Holtzman DM (2008): Endocytosis is required for synaptic activity-dependent release of amyloid-β in vivo. Neuron 58:42-51.
11. Drzezga AJ, Becker A, van Dijk KRA, Sreenivasan A, Talukdar T, Sullivan C, Schultz AP, Sepulcre J, Putcha D, Greve D, Johnson KA, Sperling RA (2011): Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden. Brain 134 (Part 6):1635-1646.
12. Fazio F, Perani D (2000): Importance of partial-volume correction in brain PET studies. J Nucl Med 41:1849-1850.
13. Filippini N, MacIntosh BJ, Hough MG, Goodwin GM, Frisoni GB, Smith SM, Matthews PM, Beckmann CF, Mackay CE (2009): Distinct patterns of brain activity in young carriers of the APOE-ε4 allele. Proc Natl Acad Sci USA 106:7209-7214.
14. Fox MD, Greicius M (2010): Clinical application of resting state functional connectivity. Front Syst Neurosci 17:4-19.
15. Fox MD, Raichle ME (2007): Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat Rev Neurosci 8:700-711.
16. Greicius MD (2008): Resting-state functional connectivity in neuropsychiatric disorders. Curr Opin Neurol 21:424-430.
17. Greicius MD, Srivastava G, Reiss AL, Menon V (2004): Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI. Proc Natl Acad Sci USA 101:4637-4642.
18. Hardy J, Selkoe DJ (2002): The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297:353-357.
19. Hedden T, van Dijk KR, Becker JA, Mehta A, Sperling RA, Johnson KA, Buckner RL (2009): Disruption of functional connectivity in clinically normal older adults harboring amyloid burden. J Neurosci 29:12686-12694.
20. Jack CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen PC, Trojanowski JQ (2010): Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9:119-128.
21. Jenkinson M, Smith SM (2001): A global optimisation method for robust affine registration of brain images. Med Image Anal 5:143-156.
22. Joachim CL, Morris JH, Selkoe DJ (1989): Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease. Am J Pathol 135:309-319.
23. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang GF, Estrada S, Ausen B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langstrom B (2004): Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 55:306-319.
24. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984): Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939-944.
25. 11C]PIB in a nondemented population. Potential antecedent marker of Alzheimer disease. Neurology 67:446-452.
26. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999): Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 56:303-308.
27. Quigley H, Colloby SJ, O'Brien JT (2011): PET imaging of brain amyloid in dementia: A review. Int J Geriatr Psychiatry 26:991-999.
28. Rabinovici GD, Jagust WJ (2009): Amyloid imaging in aging and dementia: Testing the amyloid hypothesis in vivo. Behav Neurol 21:117-128.
29. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL (2001): A default mode of brain function. Proc Natl Acad Sci USA 98:676-682.
30. Rombouts SA, Damoiseaux JS, Goekoop R, Barkhof F, Scheltens P, Smith SM, Beckmann CF (2009): Model-free group analysis shows altered BOLD fMRI networks in dementia. Hum Brain Mapp 30:256-266.
31. Sanz-Arigita EJ, Schoonheim MM, Damoiseaux JS, Rombouts SARB, Maris E, Barkhof F, Scheltens P, Stam CJ (2010): Loss of 'small-world' networks in Alzheimer's disease: Graph analysis of fMRI resting-state functional connectivity. PLoS One 5:e13788.
32. Sheline YI, Raichle ME, Snyder AZ, Morris JC, Head D, Wang S, Mintun MA (2010): Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly. Biol Psychiatry 67:584-587.
33. Smith SM (2002): Fast robust automated brain extraction. Hum Brain Mapp 17:143-155.
34. Sorg C, Riedl V, Mühlau M, Calhoun VD, Eichele T, Läer L, Drzezga A, Förstl H, Kurz A, Zimmer C, Wohlschläger AM (2007): Selective changes of resting-state networks in individuals at risk for Alzheimer's disease. Proc Natl Acad Sci USA 104:18760-18765.
35. Sperling RA, Laviolette PS, O'Keefe K, O'Brien J, Rentz DM, Pihlajamaki M, Marshall G, Hyman BT, Selkoe DJ, Hedden T, Buckner RL, Becker JA, Johnson KA (2009): Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron 63:178-188.
36. Stam CJ, Jones BF, Manshanden I, van Cappellen van Walsum AM, Montez T, Verbunt JPA, de Munck JC, van Dijk BW, Berendse HW, Scheltens P (2006): Magnetoencephalographic evaluation of resting-state functional connectivity in Alzheimer's disease. Neuroimage 32:1335-1344.
37. Svarer C, Madsen K, Hasselbalch SG, Pinborg LH, Haugbol S, Frokjaer VG, Holm S, Paulson OB, Knudsen GM (2005): MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. Neuroimage 24:969-979.
38. 18F]FFDNP PET. J Nucl Med 50:191-197.
39. 11C]PIB studies in Alzheimer's disease. Eur J Nucl Med Mol Imaging 36:1629-1638.
40. 18F]FDDNP PET images. J Neurol Neurosurg Psychiatry 81:882-884.
41. Wang K, Liang M, Wang L, Tian L, Zhang X, Li K, Jiang T (2007): Altered functional connectivity in early Alzheimer's disease: A resting-state fMRI study. Hum Brain Mapp 28:967-978.
42. 11C]2-(4′-methylaminophenyl)-6-hydroxybenzothiazole ([C-11]-6-OH-BTA-1). J Labelled Comp Radiopharm 47:679-682.
43. Wu Y, Carson RE (2002): Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging. J Cereb Blood Flow Metab 22:1440-1452.
44. Yamaguchi H, Hirai S, Morimatsu M, Shoji M, Nakazato Y (1989): Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated by β-protein immunostain. Acta Neuropathol 77:314-319.
45. 11C]PIB studies. Neuroimage 42:76-86.